Report Includes:cable wires Factory8211; 35 data tables and 43 additional tables Country specific data and analysis for US, Canada, Mexico, Germany, France, UK, Italy, Spain, Portugal, China, India, Japan, South Korea and Australia Analysis of the global market for blood testing, using quantitative and qualitative approaches Description of blood tests that are routinely used for evaluating, screening and monitoring by using analysers (including automated analysers) and integrated systems Coverage of methods of extraction of blood for blood testing, and discussion of advantages and disadvantages of blood tests Detailed study of the regulatory and reimbursement aspect of the industry Insight into current trends and recent developments in the blood testing market Comprehensive company profiles of major players in the industry, including Abbott Laboratories, Biomérieux Marcy L’etoile, F.Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends # in product launches, collaborations, mergers and acquisitions, and other agreements.Business OverviewFinancialsProducts and ServicesDevelopments and StrategiesBusiness HighlightsSYSMEX CORP., Siemens Healthineers,Chapter 5 Market Analysis by TypeChapter 6 Market Analysis by ApplicationChapter 7 Market Analysis by RegionChapter 8 Technology Outlook for Point-of-Care TestingChapter 9 Competitive LandscapeChapter 10 Regulatory and Reimbursement ScenarioChapter 11 Patent and Product Pipeline AnalysisIntroductionPatent AnalysisClinical TrialsChapter 12 Company ProfilesA.

The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection and pregnancy.The Asia-Pacific region has the highest potential for growth in the blood testing industry during the forecast period owing to the large aging population, the rising incidence of chronic and infectious diseases, blood disorders, cancer, diabetes, cardiovascular diseases, increasing disposable income, awareness about healthcare and disease complications and a growing number of hospitals and laboratories. Blood tests are being developed to detect multiple cancers from a single drop of blood, to detect Alzheimer’s disease well before the onset of symptoms, to predict pre-term births, and to predict risk of autism and even the prognosis of anti-depressant therapy in patients.A. This is particularly true considering the continuously expanding parameters which can be tested in blood.Blood testing for oncology is one of the most rapidly developing fields in the market, with the higher incidence of cancers and the development of companion diagnostics and precision medicine for the treatment of these diseases contributing to growth.

In recent years, there has been a surge in the growth of POCT, which has helped near-patient blood testing and diagnosis, in-home monitoring devices, and real-time tracking of blood glucose levels, lipid levels and blood clotting parameters.Business OverviewDIASORINBusiness OverviewF.The report also includes a discussion of the market’s major drivers and global dynamics along with the political, economic, social and technological factors that impact the market. New and exciting studies are being conducted for the development of blood tests that may cause breakthroughs in the diagnosis of diseases; such diagnoses were not previously possible. This report also covers home-monitoring devices and test strips and the associated calibration reagents for diabetes and lipid profiles using finger pricks. LTD.Blood Testing IndustryDescriptionWiseguyreports. The report provides market size estimates for the year 2017 (considered as a base year) and 2018, as well as a forecast through 2023.

The global burden of chronic non-communicable, infectious and lifestyle diseases is rapidly increasing, and many patients suffer from multiple diseases, which leads to morbidity, loss of function and death.Business OverviewHMD BIOMEDICAL INC. Genetic testing has achieved significant progress over the years and shows great promise for early cancer diagnosis. This trend is expected to continue with the development of newer technologies that integrate the accuracy and reliability of laboratory testing with the comfort of selfmonitoring.Business OverviewGRIFOLS S.Com Adds “Blood Testing -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research DatabaseThe global blood testing market was estimated at REDACTED in 2017 and is expected to grow at a CAGR of REDACTED to reach REDACTED in 2023.North America holds the largest share in the blood testing market, followed by Europe, due to high healthcare expenditures, the presence of excellent healthcare facilities and infrastructure, government funding for research and development of newer and innovative products, and the development of technology for rapid and accurate diagnosis of diseases.This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. LTD. Therefore, an early and reliable diagnosis through blood testing is important for the detection, monitoring and treatment of the diseases